← FDA Drug Approvals (Drugs@FDA)
MESALAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SINOTHERAPEUTICS INC · Approved 2023-05-12
Drug application
- FDA Application #
ANDA217337- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MESALAMINE
- Generic name
- MESALAMINE
- Active ingredients
- MESALAMINE
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SINOTHERAPEUTICS INC
- Manufacturer
- Lannett Company Inc.
- First approval
- 2023-05-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown